Cancer Research UK logo.
SearchDonate
  • Search

A trial of triamcinolone with hormone therapy for prostate cancer (TRICREST)

Overview

Cancer types:

Prostate cancer

Status:

Closed

Phase:

Phase 2

Details

This study is looking at a steroid drug called triamcinolone (pronounced try-am-sin-o-lone) for prostate cancer that has stopped responding to hormone therapy.

Recruitment start: 17 January 2012

Recruitment end: 15 February 2018

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Jonathan Shamash

Supported by

Barts Health NHS Trust

Experimental Cancer Medicine Centre (ECMC)

Orchid Cancer Charity

Last reviewed: 16 Feb 2018

CRUK internal database number: 8200

Help and support